Overview of Dr. Dixon
Dr. Matthew Dixon is a Hepatopancreatobiliary surgeon in Chicago, IL and is affiliated with Rush University Medical Center. He has a passion and interest in the clinical treatment of patients with cancers of the liver, metastatic disease of the liver (such as metastatic colorectal cancer), benign liver tumors, bile duct cancer, pancreatic cancer, pancreatic cysts, neuroendocrine tumors and other types of rare pancreatic tumors.
Office
1725 W Harrison St, Suite 810
Chicago, IL 60614Fax+1 312-563-2775- Is this information wrong?
Education & Training
- Maimonides Medical CenterResidency, Surgery, 2009 - 2014
- St. George's University School of MedicineClass of 2009
Certifications & Licensure
- IL State Medical License 2022 - 2026
- IN State Medical License 2022 - 2025
- PA State Medical License 2018 - 2023
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 15 citationsThe Future Liver Remnant: Definition, Evaluation, and ManagementMatthew Dixon, Jeffrey Cruz, Nabeel Sarwani, Niraj J. Gusani
The American Surgeon. 2021-02-01 - 77 citationsHow many lymph nodes should be assessed in patients with gastric cancer? A systematic reviewRajini Seevaratnam, Alina Bocicariu, Roberta Cardoso, Lavanya Yohanathan, Matthew Dixon
Gastric Cancer. 2012-08-16 - 7 citationsAdjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology.Elizabeth J. Olecki, Kelly A. Stahl, Madeline B. Torres, June S. Peng, Matthew Dixon
Annals of Surgical Oncology. 2021-01-31
Hospital Affiliations
- Rush University Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: